Pharma Stability: Insights, Guidelines, and Expertise
The purpose of this SOP is to outline the procedure for conducting stability testing for pediatric drug formulations in accordance with US FDA and European Medicines Agency (EMA) guidelines. This ensures that pediatric formulations retain their safety, quality, and efficacy throughout their shelf life, meeting all regulatory standards.
Click to read the full article.
The purpose of this SOP is to establish a procedure for conducting stability testing for biosimilar products in accordance with the World Health Organization (WHO) guidelines. This ensures that biosimilars maintain their safety, quality, and efficacy throughout their shelf life and meet global regulatory standards.
Click to read the full article.
The purpose of this SOP is to outline the procedure for implementing stability testing in pharmaceutical development in accordance with ICH Q8 guidelines. This ensures that stability data is integrated into the design and development of drug products, supporting their quality throughout their lifecycle.
Click to read the full article.
The purpose of this SOP is to establish a procedure for conducting stability testing of modified-release formulations in compliance with relevant regulatory guidelines. This ensures that these formulations maintain their desired release profiles, quality, safety, and efficacy throughout their shelf life.
Click to read the full article.
The purpose of this SOP is to establish a procedure for applying ICH Q10 guidelines to the pharmaceutical quality system (PQS) in the context of stability studies. This ensures a systematic approach to managing quality throughout the product lifecycle.
Click to read the full article.
The purpose of this SOP is to define a procedure for conducting stability studies for drugs with complex active pharmaceutical ingredients (APIs) in compliance with relevant regulatory guidelines. This ensures that such drugs maintain their quality, safety, and efficacy throughout their shelf life.
Click to read the full article.
Stability SOP: Interpreting Regulatory Expectations for Compliance-Ready Procedures Updated September 2025 — A detailed interpretation of regulatory requirements for developing robust SOPs in pharmaceutical stability studies, including FDA, EMA, WHO, and CDSCO perspectives. Why Stability SOPs Are Critical for Compliance Standard Operating Procedures (SOPs) are the backbone of any pharmaceutical quality system, and in stability…
Read More “Stability SOP: Step-by-Step FDA/ICH Compliance-Ready Procedures & Checklist” »
The purpose of this SOP is to define a procedure for implementing ICH Q1A(R2) guidelines for stability testing in tropical and subtropical regions. This ensures that drug products maintain their quality, safety, and efficacy under challenging climatic conditions.
Click to read the full article.
The purpose of this SOP is to establish a procedure for conducting stability testing for drug products containing multiple active ingredients in compliance with relevant regulatory guidelines. This ensures that the product maintains its quality, safety, and efficacy throughout its shelf life.
Click to read the full article.
The purpose of this SOP is to outline the procedure for conducting stability studies for drug products containing novel excipient-drug combinations in compliance with relevant regulatory guidelines. This ensures that the novel combination maintains its quality, safety, and efficacy throughout its shelf life.
Click to read the full article.